Immix Biopharma (IMMX) Institutional Ownership $2.65 -0.07 (-2.57%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.64 0.00 (-0.19%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Immix Biopharma (NASDAQ:IMMX)CurrentInstitutional OwnershipPercentage11.26%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$256.38KNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$642.55K Get IMMX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMMX Institutional Buying and Selling by Quarter Immix Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/17/2025 Tritonpoint Wealth LLC24,526$51K0.0%N/A0.088% 5/13/2025Tocqueville Asset Management L.P.29,300$49K0.0%-23.5%0.105% 2/14/2025Jane Street Group LLC17,523$39K0.0%N/A0.064% 2/6/2025SBI Securities Co. Ltd.17,500$38K0.0%N/A0.064% 1/13/2025 FNY Investment Advisers LLC28,750$63K0.0%N/A0.105% 11/16/2024Geode Capital Management LLC150,082$224K0.0%+5.6%0.546% 10/22/2024Private Advisor Group LLC34,325$51K0.0%-47.3%0.130% 8/16/2024Invst LLC27,000$57K0.0%N/A0.102% 8/12/2024XTX Topco Ltd17,663$35K0.0%-66.2%0.067% 8/9/2024Renaissance Technologies LLC154,685$306K0.0%-41.7%0.586% Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/7/2024 AIGH Capital Management LLC1,406,680$2.79M0.9%-9.5%5.326% 5/10/2024Tocqueville Asset Management L.P.37,800$116K0.0%+89.0%0.143% 4/26/2024 Tritonpoint Wealth LLC24,526$75K0.0%N/A0.093% 2/7/2024Jump Financial LLC18,500$128K0.0%N/A0.093% 2/6/2024Private Advisor Group LLC99,775$690K0.0%N/A0.502% 2/1/2024 OLD National Bancorp IN10,000$69K0.0%N/A0.050% 1/30/2024Imprint Wealth LLC34,483$239K0.2%+49.4%0.174% 11/9/2023Tocqueville Asset Management L.P.12,000$41K0.0%N/A0.061% 10/23/2023Commonwealth Equity Services LLC28,855$99K0.0%+26.4%0.147% 7/28/2023 Koshinski Asset Management Inc.51,001$137K0.0%N/A0.339% 7/25/2023 UMB Bank n.a.72,639$195K0.0%-26.8%0.483% 4/11/2023 UMB Bank n.a.99,300$181K0.0%N/A0.714% 2/10/2023Murchinson Ltd.67,200$154K0.0%N/A0.482% 2/7/2023Lynwood Capital Management Inc.25,000$58K0.1%N/A0.179% 2/1/2023Bank of Montreal Can15,000$36K0.0%N/A0.108% 5/11/2022InterOcean Capital Group LLC15,900$38K0.0%N/A0.115% 2/14/2022Altium Capital Management LP122,388$436K0.1%N/A1.616% 2/14/2022Murchinson Ltd.695,600$2.48M0.2%N/A9.183% 2/9/2022Context Capital Management LLC11,532$41K0.0%N/A0.152% 2/2/2022PVG Asset Management Corp20,000$71K0.3%N/A0.264% 2/1/2022Eidelman Virant Capital29,856$103K0.0%N/A0.394% (Data available from 1/1/2016 forward) IMMX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMMX shares? During the previous two years, 15 institutional investors and hedge funds held shares of Immix Biopharma. The most heavily invested institutionals were AIGH Capital Management LLC ($2.79M), Renaissance Technologies LLC ($306K), Imprint Wealth LLC ($239K), Geode Capital Management LLC ($224K), Jump Financial LLC ($128K), Commonwealth Equity Services LLC ($99K), and OLD National Bancorp IN ($69K).Learn more on Immix Biopharma's institutional investors. What percentage of Immix Biopharma's stock is owned by institutional investors? 11.26% of Immix Biopharma's stock is owned by institutional investors. Learn more on IMMX's institutional investor holdings. Which institutional investors have been buying Immix Biopharma's stock? Of the 12 institutional investors that purchased Immix Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Private Advisor Group LLC ($99.78K), Tritonpoint Wealth LLC ($49.05K), Tocqueville Asset Management L.P. ($29.80K), FNY Investment Advisers LLC ($28.75K), Invst LLC ($27K), Jump Financial LLC ($18.50K), and Jane Street Group LLC ($17.52K). How much institutional buying is happening at Immix Biopharma? Institutional investors have bought a total of 123,253 shares in the last 24 months. This purchase volume represents approximately $256.38K in transactions. Which of Immix Biopharma's major shareholders have been selling company stock? The following institutional investors have sold Immix Biopharma stock in the last 24 months: AIGH Capital Management LLC ($148.32K), Renaissance Technologies LLC ($110.82K), XTX Topco Ltd ($34.53K), Private Advisor Group LLC ($30.85K), and Tocqueville Asset Management L.P. ($9K). How much institutional selling is happening at Immix Biopharma? Institutional investors have sold a total of 333,519 shares in the last 24 months. This volume of shares sold represents approximately $642.55K in transactions. Related Companies Altimmune Institutional Ownership ADC Therapeutics Institutional Ownership Allogene Therapeutics Institutional Ownership Benitec Biopharma Institutional Ownership Inventiva Institutional Ownership Tonix Pharmaceuticals Institutional Ownership Annexon Institutional Ownership Esperion Therapeutics Institutional Ownership scPharmaceuticals Institutional Ownership Aardvark Therapeutics Institutional Ownership This page (NASDAQ:IMMX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.